# A Phase 1 Safety Study of Dengusiil in Healthy Adults

> **NCT04035278** · PHASE1 · COMPLETED · sponsor: **Serum Institute of India Pvt. Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Prevention of Dengue Fever

## Interventions

- **BIOLOGICAL:** Dengusiil
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04035278
- **Lead sponsor:** Serum Institute of India Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2021-06-11
- **Final completion:** 2021-06-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04035278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04035278, "A Phase 1 Safety Study of Dengusiil in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04035278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*